Apotea AB (publ) (OSTO:APOTEA) Other Current Receivables: kr128 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:APOTEA Apotea AB (publ) OSTO:APOTEA
18 GF Score
Price kr72.55
! 1 Warning Sign
View Full Analysis

What is Apotea AB (publ) Other Current Receivables?

Apotea AB (publ) OSTO:APOTEA -0.34% 18 Other Current Receivables is kr128 Mil as of Jun. 2026. GuruFocus rates OSTO:APOTEA with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

Apotea AB (publ)'s Other Current Receivables for the quarter that ended in Jun. 2026 was kr128 Mil.

Apotea AB (publ)'s quarterly Other Current Receivables increased from Dec. 2025 (kr35.30 Mil) to Mar. 2026 (kr108.20 Mil) and increased from Mar. 2026 (kr108.20 Mil) to Jun. 2026 (kr128.30 Mil).

Apotea AB (publ)'s annual Other Current Receivables increased from Dec. 2023 (kr22.60 Mil) to Dec. 2024 (kr30.40 Mil) and increased from Dec. 2024 (kr30.40 Mil) to Dec. 2025 (kr35.30 Mil).

Apotea AB (publ) Other Current Receivables Related Terms

Apotea AB (publ) Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Apotea AB (publ)'s Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apotea AB (publ) Other Current Receivables Chart

Apotea AB (publ) Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
24.00 35.10 22.60 30.40 35.30

Apotea AB (publ) Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 76.40 111.60 35.30 108.20 128.30
OSTO:APOTEA
18GF Score
Apotea AB (publ) OSTO:APOTEA
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apotea AB (publ) Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of kr128 Mil mean?
Apotea AB (publ) (OSTO:APOTEA) has a Other Current Receivables of kr128 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Apotea AB (publ) and its competitors.
Is Apotea AB (publ)'s Other Current Receivables too high?
Apotea AB (publ)'s current Other Current Receivables is kr128 Mil. Overall, Apotea AB (publ) has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s Other Current Receivables compare to competitors?
Apotea AB (publ)'s Other Current Receivables of kr128 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Healthcare Providers & Services company?
A good Other Current Receivables depends on the Healthcare Providers & Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Apotea AB (publ) and its competitors. Apotea AB (publ)'s current Other Current Receivables is kr128 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (OSTO:APOTEA) has a current Other Current Receivables of kr128 Mil. The current Other Current Receivables is kr128 Mil. Apotea AB (publ)'s overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Apotea AB (publ) (OSTO:APOTEA), the current Other Current Receivables is kr128 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apotea AB (publ) Business Description

Other Exchanges V30:Germany
Address Sveavagen 168, Stockholm, SWE, 11346
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
18GF Score

Get the complete analysis for OSTO:APOTEA

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr72.55
Price